Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours
The DOI matches its Crossref record; 28 of the 31 references it cites were found in a registry or an index.
Abstract
Apoptosis is a genetically encoded programme of cell death that can be activated under physiological conditions and may be an important safeguard against tumour development. Regions of low oxygen (hypoxia) and necrosis are common features of solid tumours. Here we report that hypoxia induces apoptosis in oncogenically transformed cells and that further genetic alterations, such as loss of the p53 tumour-suppressor gene or overexpression of the apoptosis-inhibitor protein Bcl-2, substantially reduce hypoxia-induced cell death. Hypoxia also selects for cells with defects in apoptosis, because small numbers of transformed cells lacking p53 overtake similar cells expressing wild-type p53 when treated with hypoxia. Furthermore, highly apoptotic regions strongly correlate with hypoxic regions in transplanted tumours expressing wild-type p53, whereas little apoptosis occurs in hypoxic regions of p53-deficient tumours. We propose that hypoxia provides a physiological selective pressure in tumours for the expansion of variants that have lost their apoptotic potential, and in particular for cells acquiring p53 mutations.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Giaccia and co-workers demonstrated that hypoxia can induce tumor cell apoptosis, an effect that was reduced by loss of p53 tumor suppressor function or overexpression of anti-apoptotic Bcl-2 (Graeber et al., 1996).”
From Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer (2016) · cites this paper as Graeber et al., 1996
In the citing paper
“Therefore, hypoxia can exert a selective pressure that leads to expansion of tumor cells with reduced apoptotic capacity due to, for example, TP53 mutations (Graeber et al., 1996).”
From Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer (2016) · cites this paper as Graeber et al., 1996
In the citing paper
“Hypoxia and/or HIFs can mediate chemotherapy resistance through additional mechanisms including: a) hypoxia-induced decreases in tumor cell proliferation (Tannock, 1968); b) metabolic reprogramming; c) hypoxia-driven selection of p53-mutated tumor cells with less apoptotic capacity (Graeber et al., 1996); and d) inhibition of DNA damage (Sullivan & Graham, 2009).”
From Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer (2016) · cites this paper as Graeber et al., 1996
Citations
Cites
Apoptosis in the Pathogenesis and Treatment of Disease
Thompson, C. B. (1995) · Science · doi:10.1126/science.7878464 · Cited by 6,524
Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death
Hockenbery, D., Nuñez, G., Milliman, C., Schreiber, R. D., & Korsmeyer, S. J. (1990) · Nature · doi:10.1038/348334a0 · Cited by 3,720
Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis.
Greenblatt, M. S., Bennett, W. P., Hollstein, M., & Harris, C. C. (1994) · PubMed · Cited by 3,463
p53-dependent apoptosis modulates the cytotoxicity of anticancer agents
Lowe, S. W., Ruley, H. E., Jacks, T., & Housman, D. E. (1993) · Cell · doi:10.1016/0092-8674(93)90719-7 · Cited by 2,925
Self-citationDranoff, G., Jaffee, E., Lazenby, A., Golumbek, P., Levitsky, H., Brose, K., Jackson, V, Hamada, H., Pardoll, D., & Mulligan, R. C. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.8.3539 · Cited by 2,818
Production of high-titer helper-free retroviruses by transient transfection.
Pear, W. S., Nolan, G. P., Scott, M. L., & Baltimore, D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.18.8392 · Cited by 2,266
The Histological Structure of Some Human Lung Cancers and the Possible Implications for Radiotherapy
Thomlinson, R. H., & Gray, L. H. (1955) · British Journal of Cancer · doi:10.1038/bjc.1955.55 · Cited by 2,219
Mice Lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control
Deng, C., Zhang, P., Wade Harper, J., Elledge, S. J., & Leder, P. (1995) · Cell · doi:10.1016/0092-8674(95)90039-x · Cited by 2,113
The Molecular Genetics of Cancer
Bishop, J. M. (1987) · Science · doi:10.1126/science.3541204 · Cited by 1,688
Sunburn and p53 in the onset of skin cancer
Ziegler, A., Jonason, A. S., Leffellt, D. J., Simon, J. A., Sharma, H. W., Kimmelman, J., Remington, L., Jacks, T., & Brash, D. E. (1994) · Nature · doi:10.1038/372773a0 · Cited by 1,497
Self-citation
Research works printed but not linked: 9
- Vaupel, P. W. & Hockel, M. in Tumor Oxygenation (eds Vaupel, P. W., Kelleher, D. K. & Gunderoth, M.) 219–232 (Gustav Fischer, Stuttgart, 1995).
- Lord, E. M., Harwell, L. & Koch, C. J. Cancer Res. 53, 5721–5726 (1993).
- Bardeesy, N., Beckwith, J. B. & Pelletier, J. Cancer Res. 55, 215–219 (1995).
- Baker, S. J. et al. Cancer Res. 50, 7717–7722 (1990).
- Sinicrope, F. A. et al. Cancer Res. 55, 237–241 (1995).
- Bedi, A. et al. Cancer Res. 55, 1811–1816 (1995).
- Lotem, J. & Sachs, L. Cell Growth. Differ. 4, 41–47 (1993).
- Lowe, S. W. Curr. Opin. Oncol. (in the press).
- Greenblatt, M. S., Bennett, W. P., Hollstein, M. & Harris, C. C. Cancer Res. 54, 4855–4878 (1994).
Cited by
Items 501–600 of 1,006
Brown, L. M., Cowen, R. L., Debray, C., Eustace, A., Erler, J. T., Sheppard, F. C., Parker, C. A., Stratford, I. J., & Williams, K. J. (2006) · Molecular Pharmacology · doi:10.1124/mol.105.015743 · Cited by 125
“Preclinical observations have additionally demonstrated that hypoxia is a selective pressure for genomic instability with acquired drug resistance and loss of apoptotic potential reported for cells exposed to hypoxia both in vitro and in vivo (Young et al., 1988; Teicher, 1994; Graeber et al., 1996).”
BackgroundCancer Metabolism Drives a Stromal Regenerative Response
Schwörer, S., Vardhana, S. A., & Thompson, C. B. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.01.015 · Cited by 123
“The growth of cancer cells frequently outstrips the local blood supply, leading to regional hypoxia (Dewhirst et al., 1994; Graeber et al., 1996; Helmlinger et al., 1997) (Figure 3).”
BackgroundOehler, M. K., Norbury, C. J., Hague, S. J., REES, M. C. P., & Bicknell, R. (2001) · Oncogene · doi:10.1038/sj.onc.1204422 · Cited by 133
“It is thought that hypoxia functions as a selective pressure for solid tumours, leading to the progression to a more malignant phenotype by selecting for an apoptosis-resistant population of cells which show a distinct expression of hypoxia controlled genes (Graeber et al., 1996).”
BackgroundSowter, H. M., Ferguson, M., Pym, C., Watson, P., Fox, S. B., Han, C., & Harris, A. L. (2003) · The Journal of Pathology · doi:10.1002/path.1486 · Cited by 124
“Although the mechanism linking necrosis and poor prognosis is unknown, cells in culture are able to escape hypoxia-induced cell death and acquire sustained resistance to apoptotic signals [3].”
BackgroundDevireddy, L. R., & Jones, C. (1999) · Journal of Virology · doi:10.1128/jvi.73.5.3778-3788.1999 · Cited by 125
Identification of a Novel Small Molecule HIF-1α Translation Inhibitor
Narita, T., Yin, S., Gelin, C. F., Moreno, C. S., Yepes, M., Nicolaou, K. C., & Van Meir, E. G. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-3180 · Cited by 123
O’Connor, J. P. B., Naish, J. H., Parker, G. J. M., Waterton, J. C., Watson, Y., Jayson, G. C., Buonaccorsi, G. A., Cheung, S., Buckley, D. L., McGrath, D. M., et al. (2009) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2008.12.040 · Cited by 124
Burri, P., Djonov, V., Aebersold, D. M., Lindel, K., Studer, U., Altermatt, H. J., Mazzucchelli, L., Greiner, R. H., & Gruber, G. (2003) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(02)04579-0 · Cited by 141
Ballinger, J. R. (2001) · Seminars in Nuclear Medicine · doi:10.1053/snuc.2001.26191 · Cited by 123
Hypoxia-inducible factor 1 (HIF-1) in cancer
Quintero, M., Mackenzie, N., & Brennan, P. A. (2004) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2004.03.008 · Cited by 139
Hypoxia in prostate cancer: A powerful shield against tumour destruction?
Marignol, L. H., Coffey, M. A., Lawler, M., & Hollywood, D. P. (2008) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2008.01.006 · Cited by 139
“Loss of p53 activity in tumour cells is indeed associated with reduced cellular apoptosis potential in response to hypoxia.(86) Bcl-2 overexpression in radical prostatectomy specimens (as detected by immunochemistry) was positively associated with a high risk of biochemical failure in clinically localized prostate can…”
BackgroundOsteocyte hypoxia: a novel mechanotransduction pathway
Dodd, J. S., Raleigh, J. A., & Gross, T. S. (1999) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1999.277.3.c598 · Cited by 123
“The colocalization of hypoxia and apoptosis in tumors (9) suggests that the potential relation between osteocyte hypoxia and osteocyte apoptosis may prove a fruitful area of study.”
BackgroundDing, Z., Yang, L., Xie, X., Xie, F., Pan, F., Li, J., He, J., & Liang, H. (2010) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-010-0828-5 · Cited by 116
“(Graeber et al. 1996) have revealed that a number of factors associated either directly or indirectly with tumor hypoxia contributed to resistance to anticancer drugs in a solid tumor in vivo.”
BackgroundDriessen, A., Landuyt, W., Pastorekova, S., Moons, J., Goethals, L., Haustermans, K., Nafteux, P., Penninckx, F., Geboes, K., Lerut, T., et al. (2006) · Annals of Surgery · doi:10.1097/01.sla.0000201452.09591.f3 · Cited by 124
Biology of pancreatic stellate cells—more than just pancreatic cancer
Ferdek, P. E., & Jakubowska, M. A. (2017) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-017-1968-0 · Cited by 115
“Poor oxygenation (hypoxia) and limited nutrient availability are the hallmarks of solid tumours [39], including PDAC.”
BackgroundHypoxia inducible factor-2α: a critical mediator of aggressive tumor phenotypes
Qing, G., & Simon, M. C. (2009) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2008.12.001 · Cited by 135
Tumor Angiogenesis: Insights and Innovations
Nussenbaum, F., & Herman, I. M. (2010) · Journal of Oncology · doi:10.1155/2010/132641 · Cited by 116
“VEGF is stimulated by the hypoxic conditions near the central necrotic tissue of solid tumors [222].”
Wnt–β-catenin Signaling Protects Against Hepatic Ischemia and Reperfusion Injury in Mice
Lehwald, N., Tao, G., Jang, K. Y., Sorkin, M., Knoefel, W. T., & Sylvester, K. G. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.04.051 · Cited by 120
Apoptosis in Neurological Disease
Sean, I. S., & Daniel, M. R. (1998) · Neurosurgery · doi:10.1097/00006123-199803000-00026 · Cited by 124
Proteasome inhibition circumvents solid tumor resistance to topoisomerase II-directed drugs.
Ogiso, Y., Tomida, A., Lei, S., Ōmura, S., & TSURUO, T. (2000) · PubMed · Cited by 141
CURRENT TOPIC: To Be, or Not to Be, That is the Question. Apoptosis in Human Trophoblast
Levy, R., & Nelson, D. M. (2000) · Placenta · doi:10.1053/plac.1999.0450 · Cited by 144
“Hypoxia is a known trigger of apoptosis in different tissues (Linnik, Zobrist and Hatfield, 1993; Graeber et al., 1996) and hypoxia may trigger apoptosis in the placenta as a possible mechanism of pregnancy related complications.”
BackgroundBiroccio, A., Candiloro, A., Mottolese, M., Sapora, O., Albini, A., Zupi, G., & Bufalo, D. D. (2000) · The FASEB Journal · doi:10.1096/fasebj.14.5.652 · Cited by 139
“A recent study has indicated that the oncogene activation observed during tumor development and the tumor microenvironment play critical and perhaps synergistic roles in regulating cell viability (30).”
BackgroundTumor Hypoxia and Gene Expression: Implications for Malignant Progression and Therapy
Sutherland, R. M. (1998) · Acta Oncologica · doi:10.1080/028418698430278 · Cited by 119
Bauer, G. (2007) · International Journal of Radiation Biology · doi:10.1080/09553000701727523 · Cited by 125
“…with an impact on their intra- and extracellular signaling chemistry, life span, resistance to antitumor mechanisms and many other features (Bauer 1995, 1996, 2000, Graeber et al. 1996, Kinzler & Vogelstein 1996, Deichman et al. 1998, Deichman 2000, Hanahan & Weinberg 2000, Barcellos-Hoff 2001a).”
BackgroundChen, E. Y., Fujinaga, M., & Giaccia, A. J. (1999) · Teratology · doi:10.1002/(sici)1096-9926(199910)60:4<215::aid-tera6>3.0.co;2-2 · Cited by 119
Self-citationAuvinen, M. I., Laine, A., Paasinen-Sohns, A., Kangas, A., Kangas, L., Saksela, O., Andersson, L. C., & Hölttä, E. (1997) · PubMed · Cited by 121
Zhang, X., Kon, T., Wang, H., Li, F., Huang, Q., Rabbani, Z. N., Kirkpatrick, J. P., Vujaskovic, Z., Dewhirst, M. W., & Li, C.-Y. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2301 · Cited by 120
“Specifically, it plays a critical role in promoting mutagenesis and selecting for malignant tumor growth (4).”
BackgroundSanabria, L. M., Rodríguez, M. E., Cogno, I. S., Vittar, N. B. R., Pansa, M. F., Lamberti, M. J., & Rivarola, V. A. (2012) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2012.10.001 · Cited by 129
Proline Oxidase Promotes Tumor Cell Survival in Hypoxic Tumor Microenvironments
Liu, W., Glunde, K., Bhujwalla, Z. M., Raman, V., Sharma, A., & Phang, J. M. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-0080 · Cited by 127
“POX induces protective autophagy, but not apoptosis under hypoxia It is well known that hypoxia can increase both apoptotic cell death and autophagy, the latter of which is a survival strategy of cancer cells (23, 24).”
Hussain, Z., Rahim, M. A., Jan, N., Shah, H., Rawas‐Qalaji, M., Khan, S., Sohail, M. F., Thu, H. E., Ramli, N. A., Sarfraz, R. M., et al. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.05.018 · Cited by 123
Involvement of p38 in Apoptosis-associated Membrane Blebbing and Nuclear Condensation
Deschesnes, R. G., Huot, J., Valerie, K. C., & Landry, J. (2001) · Molecular Biology of the Cell · doi:10.1091/mbc.12.6.1569 · Cited by 131
“Cells expressing deregulated c-Myc are hypersensitive to induction of apoptosis by a number of distinct stresses such as serum or growth factor starvation, exposures to cancer chemotherapeutic drugs, radiation, hypoxia, and death receptor activation (Askew et al., 1991; Evan et al., 1992; Graeber et al., 1996; Guo et…”
BackgroundInfluentialApoptosis: An Overview of the Process and Its Relevance in Disease
Webb, S. J., Harrison, D. J., & Wyllie, A. H. (1997) · Advances in pharmacology · doi:10.1016/s1054-3589(08)61052-2 · Cited by 129
Bassiouni, R., Idowu, M. O., Gibbs, L. D., Robila, V., Grizzard, P. J., Webb, M. G., Song, J., Noriega, A., Craig, D. W., & Carpten, J. D. (2022) · Cancer Research · doi:10.1158/0008-5472.can-22-2682 · Cited by 142
p53: Twenty five years understanding the mechanism of genome protection
Gómez-Lázaro, M., Fernández-Gómez, F.-J., & Jordán, J. (2004) · Journal of Physiology and Biochemistry · doi:10.1007/bf03167075 · Cited by 134
Involvement of a ferroprotein sensor in hypoxia-mediated inhibition of neutrophil apoptosis
Mecklenburgh, K. I., Walmsley, S. R., Cowburn, A. S., Wiesener, M., Reed, B. J., Upton, P. D., Deighton, J., Greening, A. P., & Chilvers, E. R. (2002) · Blood · doi:10.1182/blood-2002-02-0454 · Cited by 117
Mutagenesis induced by the tumor microenvironment
Yuan, J., & Glazer, P. M. (1998) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/s0027-5107(98)00042-6 · Cited by 118
Hypoxia, drug therapy and toxicity
Lee, K., Roth, R. A., & LaPres, J. J. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2006.08.001 · Cited by 136
Hedley, D. W., Pintilie, M., Woo, J. M. P., Morrison, A. J., Birle, D. C., Fyles, A., Milosevic, M., & Hill, R. P. (2003) · PubMed · Cited by 131
Ohiro, Y., Garkavtsev, I., Kobayashi, S., Sreekumar, K. R., Nantz, R., Higashikubo, B. T., Duffy, S., Higashikubo, R., Usheva, A., Gius, D. R., et al. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)03049-1 · Cited by 128
Early Wound Healing Exhibits Cytokine Surge Without Evidence of Hypoxia
Haroon, Z. A., Raleigh, J. A., Greenberg, C. S., & Dewhirst, M. W. (2000) · Annals of Surgery · doi:10.1097/00000658-200001000-00020 · Cited by 117
Braun, R. D., Lanzen, J. L., & Dewhirst, M. W. (1999) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1999.277.2.h551 · Cited by 119
“More recently hypoxia has been shown to exert a selective pressure for the survival of those cells with lower apoptotic potential (15), to alter gene expression such as those involved in cell cycle regulation and cytokine production (10), to increase mutation frequency (35), and to impact treatment outcome and patient…”
BackgroundInduction of TNF‐sensitive cellular phenotype by c‐Myc involves p53 and impaired NF‐κB activation
Klefström, J. T., Arighi, E., Littlewood, T., Jäättelä, M., Saksela, E., Evan, G. I., & Alitalo, K. K. (1997) · The EMBO Journal · doi:10.1093/emboj/16.24.7382 · Cited by 117
“Similar to our findings with TNF, previous reports show that certain anticancer drugs or hypoxia induce p53 without cell death in normal cells but kill cells containing E1A or deregulated c-Myc in a p53-dependent manner (Lowe et al., 1993; Graeber et al., 1996).”
ResultBirgegård, G., Gascón, P., & Ludwig, H. (2006) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2006.00739.x · Cited by 117
Cell cycle regulator E2F1 modulates angiogenesis via p53-dependent transcriptional control of VEGF
Qin, G., Kishore, R., Dolan, C., Silver, M., Wecker, A., Luedemann, C., Thorne, T., Hanley, A., Curry, C., Heyd, L., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509533103 · Cited by 116
Post, D. E., Sandberg, E. M., Kyle, M. M., Devi, N. S., Brat, D. J., Xu, Z., Tighiouart, M., & Meir, E. G. V. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3244 · Cited by 126
“Hypoxia also generates selective pressure for cells to acquire genetic alterations, such as TP53 mutations, that will circumvent hypoxia-induced apoptosis ( 27 ).”
BackgroundReplication Stress and Chromatin Context Link ATM Activation to a Role in DNA Replication
Olcina, M. M., Foskolou, I. P., Anbalagan, S., Senra, J. M., Pires, I. M., Jiang, Y., Ryan, A. J., & Hammond, E. M. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.10.019 · Cited by 112
“The hypoxia-dependent induction of the DDR early in tumorigenesis will significantly contribute to the selective pressure to lose/mutate genes such as ATM or p53 and therefore drive development of therapy-resistant disease (Graeber et al., 1996; Squatrito et al., 2010).”
BackgroundHur, E., Chang, K. Y., Lee, E., Lee, S.-K., & Park, H. (2001) · Molecular Pharmacology · doi:10.1124/mol.59.5.1216 · Cited by 110
“Several observations suggest that both gain of function in oncogenes and loss of function in tumor suppressor genes increase the accumulation of HIF-1a, which consequently induces angiogenesis and glycolysis during cancer development (Graeber et al., 1996; Carmeliet et al., 1998; Maxwell et al., 1999; Ravi et al., 200…”
Wilson, M., van Haaren, M., Harlaar, J. J., Park, H. C., Bonjer, H. J., Jeekel, J. J., Zwaginga, J. J., & Schipperus, M. R. (2017) · Surgical Oncology · doi:10.1016/j.suronc.2017.01.005 · Cited by 124
“Besides a marker of more advanced tumor stage and treatment intensity, anemia in cancer is also suggested to be a cause of inferior outcome, possibly via worsening of tumor hypoxia.(6) Hypoxia has been linked to radiotherapy and chemotherapy resistance, as oxygen is essential for the cytotoxic activities of these trea…”
BackgroundHIF-1α and p53 Promote Hypoxia-Induced Delayed Neuronal Death in Models of CNS Ischemia
Halterman, M. W., & Federoff, H. J. (1999) · Experimental Neurology · doi:10.1006/exnr.1999.7160 · Cited by 114
Evolution of p53 in hypoxia-stressed Spalax mimics human tumor mutation
Ashur-Fabian, O., Avivi, A., Trakhtenbrot, L., Adamsky, K., Cohen, M., Kajakaro, G., Joel, A., Amariglio, N., Nevo, E., & Rechavi, G. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404998101 · Cited by 112
The Hydra Phenomenon of Cancer: Why Tumors Recur Locally after Microscopically Complete Resection
Höckel, M., & Dornhöfer, N. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3868 · Cited by 118
Brusselmans, K., Bono, F., Maxwell, P., Dor, Y., Dewerchin, M., Collen, D., Herbert, J.-M., & Carmeliet, P. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c100428200 · Cited by 112
Targeting Hypoxic Cells through the DNA Damage Response
Olcina, M., Lecane, P. S., & Hammond, E. M. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0286 · Cited by 108
“has been shown to select for a loss of the apoptotic response in hypoxia (56).”
Backgroundp53 directly suppresses BNIP3 expression to protect against hypoxia‐induced cell death
Feng, X., Liu, X., Zhang, W., & Xiao, W. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.248 · Cited by 115
“Thus, the role of p53 in hypoxia-induced cell death has garnered much attention (Graeber et al, 1996; Kim et al, 1997a; Giaccia and Kastan, 1998; Stempien-Otero et al, 1999; Denko et al, 2000; Pan et al, 2004; Hammond and Giaccia, 2005).”
Backgroundp53 mediated death of cells overexpressing MDM2 by an inhibitor of MDM2 interaction with p53
Wasylyk, C., Salvi, R., Argentini, M., Dureuil, C., Delumeau, I., Abecassis, J., Debüssche, L., & Wasylyk, B. (1999) · Oncogene · doi:10.1038/sj.onc.1202528 · Cited by 124
“…in response to cellular stresses such as: DNA damage (Kastan et al., 1991), faulty spindle formation (Minn et al., 1996), depletion of oxygen (Graeber et al., 1996; An et al., 1998), diminution in ribonucleotides (Linke et al., 1996), transcription abnormalities (Andera and Wasylyk, 1997)…”
BackgroundRegulation of interleukin-8 expression by reduced oxygen pressure in human glioblastoma
Desbaillets, I., Diserens, A., de Tribolet, N., Hamou, M., & Meir, E. G. V. (1999) · Oncogene · doi:10.1038/sj.onc.1202424 · Cited by 112
“…of glioblastoma cell lines representative of the heterogeneity of this tumor type, and demonstrated that it did not depend on a particular genetic background such as p53 status (see Materials and methods). p53negative cells are known to be more resistant to hypoxic stress (Graeber et al., 1996).”
Botting, K. J., McMillen, I. C., Forbes, H., Nyengaard, J. R., & Morrison, J. L. (2014) · Journal of the American Heart Association · doi:10.1161/jaha.113.000531 · Cited by 111
Steinbach, J. P., Wolburg, H., Klumpp, A., Probst, H., & Weller, M. (2003) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401252 · Cited by 124
“The small amount of apoptosis despite extensive tumor hypoxia suggests the development of resistance to hypoxia-induced apoptosis in glioblastomas by alterations in the cell death pathway including both short-term effects such as upregulation of antiapoptotic proteins(21) and genetic selection for cells with defects i…”
BackgroundExposure to ultraviolet radiation causes apoptosis in developing sea urchin embryos
Lesser, M. P., Kruse, V. A., & Barry, T. M. (2003) · Journal of Experimental Biology · doi:10.1242/jeb.00621 · Cited by 120
Prevention of Hypoxia-Induced Apoptosis by the Angiogenic Factor Thymidine Phosphorylase
Kitazono, M., Takebayashi, Y., Ishitsuka, K., Takao, S., Tani, A., Furukawa, T., Miyadera, K., Yamada, Y., Aikou, T., & Akiyama, S. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9852 · Cited by 111
Ribonucleotide Reductase Requires Subunit Switching in Hypoxia to Maintain DNA Replication
Foskolou, I. P., Jorgensen, C., Leszczyńska, K. B., Olcina, M. M., Tarhonskaya, H., Haisma, B., D’Angiolella, V., Myers, W. K., Domene, C., Flashman, E., et al. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.03.005 · Cited by 123
“Hypoxia-induced replication stress is one of the factors proposed to contribute to the selection pressure to lose key components of the DDR, including p53 (Gorgoulis et al., 2005; Hammond et al., 2007; Graeber et al., 1996).”
BackgroundFractalkine/CX3CL1 in Neoplastic Processes
Korbecki, J., Simińska, D., Kojder, K., Grochans, S., Gutowska, I., Chlubek, D., & Baranowska‐Bosiacka, I. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103723 · Cited by 116
The hypoxic proteome is influenced by gene-specific changes in mRNA translation
Koritzinsky, M., Seigneuric, R., Magagnin, M. G., van den Beucken, T., Lambin, P., & Wouters, B. G. (2005) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2005.06.036 · Cited by 119
“Tumor hypoxia has also been associated with a lower susceptibility to apoptosis [14,19], increased angiogenesis [53,59] as well as higher metastatic and invasive potential [12,23].”
BackgroundAnaemia of cancer: an overview of mechanisms involved in its pathogenesis
Grotto, H. (2008) · Medical Oncology · doi:10.1007/s12032-007-9000-8 · Cited by 112
“It also upregulates expression of several genes associated with tumour progression, metastatic potential and angiogenesis [24, 25 ] and increases resistance to apoptosis of cells responsible for inactivation of the p53 tumour suppressor gene.”
BackgroundMack, P. C., Redman, M. W., Chansky, K., Williamson, S. K., Farneth, N. C., Lara, P. N., Franklin, W. A., Le, Q.-T., Crowley, J. J., & Gandara, D. R. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.0662 · Cited by 110
“Tumor hypoxia is associated with amplified signaling for angiogenesis, resistance to chemotherapy and radiotherapy, and increased potential for tumor progression and metastasis.(37-40) For example, cisplatin had little or no cytotoxic activity against hypoxic tumor cells in a preclinical model despite killing a large…”
BackgroundMetabolic Imaging in Multicellular Spheroids of Oncogene-transfected Fibroblasts
Walenta, S., Doetsch, J., Mueller-Klieser, W., & Kunz-Schughart, L. A. (2000) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215540004800409 · Cited by 107
“Giaccia and associates showed that the myc oncogene is involved in the balance between cell proliferation and cell death by apoptosis (Alarcon et al. 1996; Graeber et al. 1996).”
BackgroundRole of Hypoxia‐Inducible Factors in Epigenetic Regulation via Histone Demethylases
Yang, J., Ledaki, I., Turley, H., Gatter, K. C., Montero, J. M., Li, J., & Harris, A. L. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05027.x · Cited by 110
Zagzag, D., Nomura, M., Friedlander, D. R., Blanco, C., Gagner, J., Nomura, N., & Newcomb, E. W. (2003) · Journal of Cellular Physiology · doi:10.1002/jcp.10306 · Cited by 109
“For instance, p53 status is known to modulate the response of tumor cells to hypoxia (Graeber et al., 1996).”
BackgroundP53 activity is essential for normal development in Xenopus
Wallingford, J. B., Seufert, D. W., Virta, V. C., & Vize, P. D. (1997) · Current Biology · doi:10.1016/s0960-9822(06)00333-2 · Cited by 118
“Elimination of p53 activity is thought to contribute to the initiation or progression of tumorigenesis by loss of cell cycle control, genomic instability, and the acquisition of novel properties, such as resistance to hypoxia [5–8].”
BackgroundTenan, M., Fulci, G., Albertoni, M., Diserens, A., Hamou, M., Atifi, M. E., Feige, J., Pepper, M. S., & Meir, E. G. V. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.10.1789 · Cited by 113
“Prolonged exposure to anoxia can induce programmed cell death in mammalian cells (33).”
BackgroundAberrant DNA methylation associated with silencing BNIP3 gene expression in haematopoietic tumours
Murai, M., Toyota, M., Satoh, A., Suzuki, H., Akino, K., Mita, H., Sasaki, Y., Ishida, T., Shen, L., Garcia‐Manero, G., et al. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602422 · Cited by 116
“…Issa4, Y Hinoda5, T Tokino2 and K Imai1 1First Department of Internal Medicine, Sapporo Medical University, Sapporo 060-8556, Japan; 2Department of Molecular Biology, Cancer Research Institute, Sapporo Medical University, Sapporo 060-8556, Japan; 3PRESTO, JST, Kawaguchi, 332-0012, Japan;…”
BackgroundFunctional imaging of intratumoral hypoxia
Foo, S. S., Abbott, D. F., Lawrentschuk, N., & Scott, A. M. (2004) · Molecular Imaging and Biology · doi:10.1016/j.mibio.2004.06.007 · Cited by 109
Hypoxia and oxidative stress in breast cancer Hypoxia and tumourigenesis
Knowles, H. J., & Harris, A. L. (2001) · Breast Cancer Research · doi:10.1186/bcr314 · Cited by 110
“This in vitro data was supported by the spatial relationship between hypoxia, p53 and apoptosis in murine tumours in vivo, suggesting that hypoxia can promote the clonal expansion of p53mut cells in areas of tumour tissue where other cells will be killed by apoptosis [18].”
BackgroundRegulation Is in the Air: The Relationship between Hypoxia and Epigenetics in Cancer
Camuzi, D., de Amorim, Í. S. S., Pinto, L. F. R., Trivilin, L. O., Mencalha, A. L., & Soares‐Lima, S. C. (2019) · Cells · doi:10.3390/cells8040300 · Cited by 111
“Hypoxia is a double-edged sword, whereas low O2 levels induce the death of several tumor cells, the hypoxia-resistant cells exhibit a more invasive and metastatic phenotype [97].”
BackgroundImpact of the hypoxic tumor microenvironment on the regulation of cancer stem cell characteristics
Lin, Q., & Yun, Z. (2010) · Cancer Biology & Therapy · doi:10.4161/cbt.9.12.12347 · Cited by 118
Biological effects of human insulin receptor substrate-1 overexpression in hepatocytes
Tanaka, S., Mohr, L., Schmidt, E. V., Sugimachi, K., & Wands, J. R. (1997) · Hepatology · doi:10.1002/hep.510260310 · Cited by 111
Kim, H. J., Chae, H.-Z., Kim, Y.-J., Kim, Y. H., Hwang, T.-S., Park, E.-M., & Park, Y.-M. (2003) · Cell Biology and Toxicology · doi:10.1023/b:cbto.0000004952.07979.3d · Cited by 108
NF-κB subunit p65 binds to 53BP2 and inhibits cell death induced by 53BP2
Yang, J., Hori, M., Takahashi, N., Kawabe, T., Kato, H., & Okamoto, T. (1999) · Oncogene · doi:10.1038/sj.onc.1202904 · Cited by 108
“Similarly, these cells transfected with pEGFP53BP2 were stained positively by TUNEL analysis (Graeber et al., 1996) (data not shown).”
Zhang, L., & Hill, R. P. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3038 · Cited by 107
“an apoptosis-resistant cell population (20, 21).”
Anti‐apoptotic activity of low levels of wild‐type p53.
Lassus, P., Ferlin, M., Piette, J., & Hibner, U. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00834.x · Cited by 117
Huang, Y., Du, K.-M., Xue, Z.-H., Yan, H.-M., Li, D., Liu, W., Chen, Z., Zhao, Q., Tong, J.-H., Zhu, Y.-S., et al. (2003) · Leukemia · doi:10.1038/sj.leu.2403141 · Cited by 116
Immunologic Characteristics of Preeclampsia, a Comprehensive Review
Ahn, H.-K., Park, J.-C., Gilman‐Sachs, A., & Kwak-Kim, J. Y.-H. (2010) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.2010.00913.x · Cited by 115
New roles for the RB tumor suppressor protein
Liu, H., Dibling, B. C., Spike, B. T., Dirlam, A., & Macleod, K. F. (2003) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2003.11.005 · Cited by 122
Lack of Hypoxic Response in Uterine Leiomyomas despite Severe Tissue Hypoxia
Mayer, A., Höckel, M., Wree, A., Leo, C., Horn, L., & Vaupel, P. W. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6339 · Cited by 113
Laderoute, K. R., Alarcon, R. M., Brody, M. D., Calaoagan, J. M., Chen, E. Y., Knapp, A. M., Yun, Z., Denko, N. C., & Giaccia, A. J. (2000) · PubMed · Cited by 129
Self-citationp53-Dependent Association between Cyclin G and the B′ Subunit of Protein Phosphatase 2A
Okamoto, K., Kamibayashi, C., Serrano, M., Prives, C., Mumby, M. C., & Beach, D. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.11.6593 · Cited by 106
“stresses (9, 30, 34) and is responsible for apoptosis caused by hypoxic stress (8).”
BackgroundBioreductive therapies: an overview of drugs and their mechanisms of action
Rauth, A. M., Melo, T., & Misra, V. (1998) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(98)00302-2 · Cited by 107
Esposito, F., Cuccovillo, F., Vanoni, M., Cimino, F., Anderson, C. W., Appella, E., & Russo, T. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.00730.x · Cited by 110
Yamada, A., Oguchi, K., Fukushima, M., Imai, Y., & Kadoya, M. (2006) · Annals of Nuclear Medicine · doi:10.1007/bf02984657 · Cited by 106
Binding of Natively Unfolded HIF-1α ODD Domain to p53
Sánchez‐Puig, N., Veprintsev, D. B., & Fersht, A. R. (2005) · Molecular Cell · doi:10.1016/j.molcel.2004.11.019 · Cited by 116
The hypoxic tumor microenvironment and gene expression
Leo, C., Giaccia, A. J., & Denko, N. C. (2004) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2004.04.007 · Cited by 119
Self-citationHan, H. (1998) · Human Molecular Genetics · doi:10.1093/hmg/7.6.1039 · Cited by 105
“Intracellular levels of ROS become unphysiologically low in the absence of oxygen (hypoxia); in tumours, hypoxia-mediated selective cell growth confers resistance against irradiation and cytotoxic therapy ( 4 ).”
BackgroundCanman, C. E., & Kastan, M. B. (1997) · Advances in pharmacology · doi:10.1016/s1054-3589(08)61068-6 · Cited by 115
Human lung cancer and p53 : The interplay between mutagenesis and selection
Rodin, S. N., & Rodin, A. S. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.180320897 · Cited by 105
Riva, C., Donadieu, E., Magnan, J., & Lavieille, J. (2006) · Experimental Gerontology · doi:10.1016/j.exger.2006.10.014 · Cited by 105
Krick, S., Eul, B. G., Hänze, J., Savai, R., Grimminger, F., Seeger, W., & Rose, F. (2005) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2004-0314oc · Cited by 123
“This supports previous studies that demonstrated that hypoxia-inducible expression of Bnip-3L was HIF-dependent and caused apoptosis in neuroblastoma cells (40).”
Mechanisms of Hypoxic Gene Regulation of Angiogenesis Factor Cyr61 in Melanoma Cells
Kunz, M., Moeller, S., Koczan, D., Lorenz, P., Wenger, R. H., Glocker, M. O., Thiesen, H.-J., Gross, G., & Ibrahim, S. M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301373200 · Cited by 104
Hypoxia and the Malignant Glioma Microenvironment: Regulation and Implications for Therapy
Oliver, L., Olivier, C., Marhuenda, F., Campone, M., & Vallette, F. M. (2009) · Current Molecular Pharmacology · doi:10.2174/1874467210902030263 · Cited by 111
“In normal tissue p53 is a potent negative regulator of HIF-1 mediating both its apoptotic [8] and anti-angiogenic effects [9, 10].”
BackgroundKorbecki, J., Kojder, K., Barczak, K., Simińska, D., Gutowska, I., Chlubek, D., & Baranowska‐Bosiacka, I. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21165647 · Cited by 106
“This is the result of genetic instability and selective pressure due to adverse conditions of the tumor microenvironment [81,82].”
BackgroundThe role of HIF prolyl hydroxylases in tumour growth
Jokilehto, T., & Jaakkola, P. M. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2010.01030.x · Cited by 101
“Finally, hypoxia may enhance the expansion of tumour cells with diminished apoptotic potential [8].”
Background
Metadata
- Authors
- Graeber, T. G., Osmanian, C., Jacks, T., Housman, D. E., Koch, C. J., Lowe, S. W., & Giaccia, A. J.
- Affiliations
- Stanford Medicine (US)
- Howard Hughes Medical Institute (US)
- Massachusetts Institute of Technology (US)
- University of Pennsylvania (US)
- Cold Spring Harbor Laboratory (US)
- Venue
- Nature
- Published
- 1996-01
- Volume
- 379
- Issue
- 6560
- Pages
- 88-91
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2028999918
- Cited by
- 2,300
- References
- 31
- Citations by year
- 2026: 7 · 2025: 13 · 2024: 16 · 2023: 30 · 2022: 27 · 2021: 55 · 2020: 39 · 2019: 37 · 2018: 37 · 2017: 51 · 2016: 56 · 2015: 56 · 2014: 41 · 2013: 70 · 2012: 78
- FWCI
- 52.76
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Keywords
- tumor hypoxia, apoptosis, solid tumors, p53, Bcl-2, p53 deficiency, tumor necrosis, tumor heterogeneity, tumor suppressor
- MeSH terms
- Animals, Cell Line, Transformed, Cell Transformation, Neoplastic, Neoplasm Transplantation, Neoplasms, Oxygen, Proto-Oncogene Proteins, Receptors, Estrogen, Tamoxifen, Cell Hypoxia, Genes, p53, Proto-Oncogene Proteins c-myc, Apoptosis, Proto-Oncogene Proteins c-bcl-2, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.